ENST00000396253.7:c.-436C>A

Variant summary

Our verdict is . The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000396253.7(HPS5):​c.-436C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 152,328 control chromosomes in the GnomAD database, including 1,555 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1554 hom., cov: 32)
Exomes 𝑓: 0.067 ( 1 hom. )

Consequence

HPS5
ENST00000396253.7 5_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.29

Publications

16 publications found
Variant links:
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
GTF2H1 (HGNC:4655): (general transcription factor IIH subunit 1) Enables thyroid hormone receptor binding activity. Involved in positive regulation of transcription, DNA-templated and transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription factor TFIIH core complex and transcription factor TFIIH holo complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000396253.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-18322147-G-T is Benign according to our data. Variant chr11-18322147-G-T is described in ClinVar as Benign. ClinVar VariationId is 303906.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000396253.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS5
NM_181507.2
MANE Select
c.-251C>A
upstream_gene
N/ANP_852608.1Q9UPZ3-1
HPS5
NM_001440902.1
c.-251C>A
upstream_gene
N/ANP_001427831.1
HPS5
NM_001440903.1
c.-120C>A
upstream_gene
N/ANP_001427832.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS5
ENST00000396253.7
TSL:1
c.-436C>A
5_prime_UTR
Exon 1 of 22ENSP00000379552.3Q9UPZ3-2
HPS5
ENST00000438420.6
TSL:1
c.-249C>A
5_prime_UTR
Exon 1 of 22ENSP00000399590.2Q9UPZ3-2
HPS5
ENST00000399287.7
TSL:1
n.32C>A
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.138
AC:
20937
AN:
152030
Hom.:
1551
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.0560
Gnomad AMR
AF:
0.154
Gnomad ASJ
AF:
0.123
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.116
Gnomad FIN
AF:
0.176
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.149
GnomAD4 exome
AF:
0.0667
AC:
12
AN:
180
Hom.:
1
Cov.:
0
AF XY:
0.0870
AC XY:
12
AN XY:
138
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
1.00
AC:
2
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4
European-Finnish (FIN)
AF:
0.125
AC:
3
AN:
24
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0455
AC:
6
AN:
132
Other (OTH)
AF:
0.0714
AC:
1
AN:
14
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.138
AC:
20949
AN:
152148
Hom.:
1554
Cov.:
32
AF XY:
0.140
AC XY:
10440
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.187
AC:
7769
AN:
41504
American (AMR)
AF:
0.154
AC:
2359
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.123
AC:
428
AN:
3472
East Asian (EAS)
AF:
0.118
AC:
607
AN:
5156
South Asian (SAS)
AF:
0.116
AC:
559
AN:
4826
European-Finnish (FIN)
AF:
0.176
AC:
1858
AN:
10580
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6966
AN:
68002
Other (OTH)
AF:
0.147
AC:
312
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
929
1858
2787
3716
4645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
1232
Bravo
AF:
0.139
Asia WGS
AF:
0.137
AC:
478
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hermansky-Pudlak syndrome 5 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.1
DANN
Benign
0.68
PhyloP100
-1.3
PromoterAI
-0.091
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.